Financial Ratios | Unichem Laboratories Ltd. | R Wadiwala Securities Pvt Ltd

UNICHEM LABORATORIES LTD.

NSE : UNICHEMLABBSE : 506690ISIN CODE : INE351A01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE589.2014.05 (+2.44 %)
PREV CLOSE (Rs.) 575.15
OPEN PRICE (Rs.) 580.75
BID PRICE (QTY) 586.55 (7)
OFFER PRICE (QTY) 588.30 (5)
VOLUME 1190
TODAY'S LOW / HIGH (Rs.)580.75 589.20
52 WK LOW / HIGH (Rs.)365.35 606.85
NSE586.5010.9 (+1.89 %)
PREV CLOSE( Rs. ) 575.60
OPEN PRICE (Rs.) 580.60
BID PRICE (QTY) 586.90 (2)
OFFER PRICE (QTY) 587.85 (1)
VOLUME 10758
TODAY'S LOW / HIGH(Rs.) 580.60 589.00
52 WK LOW / HIGH (Rs.)367.25 607.4

Financial Ratios

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-28.724.704.88-8.55-3.38
   CEPS(Rs)-12.6117.6416.863.055.94
   DPS(Rs)0.004.004.004.004.00
   Book NAV/Share(Rs)344.18370.39362.05358.85371.69
   Tax Rate(%)-14.67-50.4933.32-24.8357.34
Margin Ratios
   Core EBITDA Margin(%)-3.395.737.38-4.60-7.08
   EBIT Margin(%)-11.842.214.58-3.66-4.44
   Pre Tax Margin(%)-13.131.734.17-4.37-5.08
   PAT Margin (%)-15.062.602.78-5.45-2.17
   Cash Profit Margin (%)-6.619.789.611.953.54
Performance Ratios
   ROA(%)-6.221.031.10-1.92-0.81
   ROE(%)-8.041.281.35-2.34-0.97
   ROCE(%)-5.601.002.11-1.46-1.85
   Asset Turnover(x)0.410.400.400.350.37
   Sales/Fixed Asset(x)0.860.991.081.061.42
   Working Capital/Sales(x)1.421.161.420.990.77
Efficiency Ratios
   Fixed Capital/Sales(x)1.171.010.930.940.71
   Receivable days147.31107.1794.63136.61110.26
   Inventory Days166.52163.63138.14121.5794.58
   Payable days179.25201.09278.03278.88224.32
Valuation Parameters
   PER(x)0.0055.4463.440.000.00
   PCE(x)-22.9214.7618.3549.5932.76
   Price/Book(x)0.840.700.850.420.52
   Yield(%)0.001.541.292.642.06
   EV/Net Sales(x)1.601.611.780.921.16
   EV/Core EBITDA(x)-304.9717.0315.5425.0991.72
   EV/EBIT(x)-13.5073.0038.80-25.17-26.12
   EV/CE(x)0.670.620.830.320.44
   M Cap / Sales1.521.441.760.971.16
Growth Ratio
   Net Sales Growth(%)5.762.8111.91-6.47-14.48
   Core EBITDA Growth(%)-105.85-14.86248.94171.43-99.55
   EBIT Growth(%)-666.54-50.70240.2222.95-101.61
   PAT Growth(%)-711.67-4.63157.03-135.48-101.00
   EPS Growth(%)-711.66-3.68157.03-152.78-100.93
Financial Stability Ratios
   Total Debt/Equity(x)0.120.130.040.070.08
   Current Ratio(x)2.482.982.722.984.05
   Quick Ratio(x)1.511.891.662.283.38
   Interest Cover(x)-9.194.6011.06-5.14-6.96
   Total Debt/Mcap(x)0.150.180.050.170.15